Hi
My husband is currently on triple therapy ( Docetaxel chemo , Zoladex every 3 months and nubeqa) he has one more chemo round left next week. He is responding well so far as PSA is declining ( see profile for PSA) . I have seen some men are talking a PARP inhibitor and nubeqa and zoladex ( or ADT equivalent med's). Have been told by some we stay the course we are on till Castrate resistant than due to BRCA2 we would than try the PARP. My questions are 1: Is the nubeqa stopped and the PARP added to the Zoladex or does he still take the nubeqa , zoladex and PARP? # 2: Is the PARP the best thing to try next when nubeqa no longer works or should he try something else first? ( if so what) ? Thanks for any info